Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 6;5(2):172-81.
doi: 10.5527/wjn.v5.i2.172.

Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction

Linda Hsu  1 , Hanhan Li  1 , Daniel Pucheril  1 , Moritz Hansen  1 , Raymond Littleton  1 , James Peabody  1 , Jesse Sammon  1
Affiliations
Review

Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction

Linda Hsu et al. World J Nephrol. .

Abstract

The management options for ureteral obstruction are diverse, including retrograde ureteral stent insertion or antegrade nephrostomy placement, with or without eventual antegrade stent insertion. There is currently no consensus on the ideal treatment or treatment pathway for ureteral obstruction owing, in part, to the varied etiologies of obstruction and diversity of institutional practices. Additionally, different clinicians such as internists, urologists, oncologists and radiologists are often involved in the care of patients with ureteral obstruction and may have differing opinions concerning the best management strategy. The purpose of this manuscript was to review available literature that compares percutaneous nephrostomy placement vs ureteral stenting in the management of ureteral obstruction from both benign and malignant etiologies.

Keywords: Pelvic malignancy; Percutaneous nephrostomy; Quality of life; Ureteral obstruction; Ureteral stents; Urinary diversion; Urinary drainage.

PubMed Disclaimer

References

    1. Feng MI, Bellman GC, Shapiro CE. Management of ureteral obstruction secondary to pelvic malignancies. J Endourol. 1999;13:521–524. - PubMed
    1. Sharer W, Grayhack JT, Graham J. Palliative urinary diversion for malignant ureteral obstruction. J Urol. 1978;120:162–164. - PubMed
    1. Holden S, McPhee M, Grabstald H. The rationale of urinary diversion in cancer patients. J Urol. 1979;121:19–21. - PubMed
    1. Fiuk J, Bao Y, Calleary JG, Schwartz BF, Denstedt JD. The use of internal stents in chronic ureteral obstruction. J Urol. 2015;193:1092–1100. - PubMed
    1. Bansal T, Mehrotra P, Jayasena D, Okolo S, Yoong W, Govind A. Obstructive nephropathy and chronic kidney disease secondary to uterine leiomyomas. Arch Gynecol Obstet. 2009;279:785–788. - PubMed